Home / Market News / $SHL.DE

$SHL.DE news and market catalysts

The 13 most recent market catalysts affecting $SHL.DE, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

13 catalysts 1 high impact 5 bullish 1 bearish Healthcare Technology
Nov 17, 2026 Corporate Catalyst Neutral Impact 55
Berenberg Updates Forecasts for Siemens Healthineers
Analyst firm Berenberg has revised its financial forecasts for Siemens Healthineers. This update is a direct consequence of the company's planned spin-off and the carve-out of its …
Nov 13, 2026 Corporate Catalyst Bearish Impact 55
Bernstein Research Downgrades Siemens Healthineers to Market-Perform
Bernstein Research downgraded Siemens Healthineers AG due to an 'improved valuation,' indicating that the stock's price has risen to a level where the analyst sees less potential f…
Nov 11, 2026 Corporate Catalyst Bullish Impact 55
Deutsche Bank Research Adjusts Siemens Healthineers Price Target
Deutsche Bank Research analyst Falko Friedrichs updated his outlook on Siemens Healthineers after the company released its fourth-quarter fiscal 2025/26 financial results. While th…
Nov 7, 2026 Corporate Catalyst Bullish Impact 55
Siemens Healthineers and Eisai China Announce Strategic Partnership for Alzheimer's Disease Care
Siemens Healthineers and Eisai China have announced a strategic partnership to tackle Alzheimer's disease in China, combining Siemens' diagnostic imaging capabilities with Eisai's …
Nov 6, 2026 Corporate Catalyst Neutral Impact 55
Analysts Update Ratings and Price Targets for Siemens Healthineers
This 8-K filing reports on two analyst actions concerning Siemens Healthineers. Barclays raised its price target and maintained an 'Overweight' rating, citing optimism for a strong…
Nov 5, 2026 Corporate Catalyst Neutral Impact 75
Siemens Healthineers Announces Diagnostics Carve-Out and Rebranding
Siemens Healthineers is undertaking a significant corporate restructuring by carving out its in vitro diagnostics unit, which will operate as Olyrian Diagnostics, and rebranding th…
Nov 5, 2026 Corporate Catalyst Bullish Impact 85
Siemens Healthineers Reports Q4 2026 Results and Announces Cost-Cutting Measures
Siemens Healthineers announced Q4 2026 results where revenue slightly beat but adjusted EBIT missed expectations, primarily due to challenges in China and the phase-out of older la…
Nov 5, 2026 Corporate Catalyst Bullish Impact 65
Siemens Healthineers Announces 'Transform4 Future' Restructuring Program
Siemens Healthineers has unveiled a new restructuring program, 'Transform4 Future,' slated for 2028-2030. This program is designed to mitigate over 300 million euros in costs arisi…
Nov 5, 2026 Corporate Catalyst Neutral Impact 75
Siemens Healthineers to Rebrand and Spin Off Diagnostics Business
Siemens Healthineers is undergoing a significant corporate restructuring by carving out its in vitro diagnostics business into a new entity, Olyrian Diagnostics, and rebranding its…
Nov 5, 2026 Corporate Catalyst Neutral Impact 75
Siemens Healthineers Announces Plan to Spin Off In Vitro Diagnostics Business
Siemens Healthineers is initiating a carve-out of its In Vitro Diagnostics business, a significant strategic shift. This decision is reportedly influenced by broader cost-cutting i…
Nov 4, 2026 Corporate Catalyst Neutral Impact 55
DHL Group CFO Melanie Kreis Nominated to Siemens Healthineers Supervisory Board
Siemens Healthineers announced the nomination of DHL Group CFO Melanie Kreis to its supervisory board. This move is part of a planned leadership transition that includes the depart…
Nov 4, 2026 Corporate Catalyst Neutral Impact 55
Siemens Healthineers Proposes Four New Supervisory Board Members
Siemens Healthineers has announced a proposal to appoint four new members to its supervisory board. This action is framed as a proactive measure to ensure long-term stability and c…
Oct 28, 2026 Corporate Catalyst Bullish Impact 55
Siemens Healthineers Announces New Radiotherapy Innovations Ahead of CIIE
Siemens Healthineers announced the launch of several new radiotherapy innovations, including the BRAVOS personalized brachytherapy solution and the Halcyon Evolve intelligent ring-…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.